0.23
—
Close of 9 Nov 2026, in HKD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Changmao Biochemical Engineering Co
Its shares trade on HKEX under the ticker 954.HK. It has been listed since 28 June 2002. In the fiscal year to 31 December 2024, it reported revenue of CN¥584.8m and a net loss of CN¥68.2m. At that date it held total assets of CN¥1.25bn and shareholders' equity of CN¥583.4m.
Changmao Biochemical Engineering Co., Ltd. engages in the production and trade of organic acids. The company is headquartered in Changzhou, Jiangsu. The company went IPO on 2002-06-28. The main products of the Company include organic acids and their derivatives with four carbons in structures. Its products include fumaric acid, maleic acid, L-malic acid, D-malic acid, DL-malic acid, L-tartaric acid, D-tartaric acid, DL-tartaric acid, L-aspartic acid and aspartame. Its products are mainly sold to food additive industries, chemical industries and pharmaceutical industries. The firm operates businesses in Mainland China, Europe, Asia Pacific, America and other regions.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Materials
- Industry
- Chemicals
- Listed since
- 28 Jun 2002
- Employees
- 574
- Website
- cmbec.com ↗
Leadership
Pay as last reported
- Xin Sheng RuiExecutive Chairman of the Board, Chief Compliance Officer, since 2014CN¥867,000
- Chun PanChief Executive Officer, General Manager, Executive DirectorCN¥580,000
- Yi Dong WanDeputy General Manager, since 2014
- A. Xing LuManager - Sales Department
- Qin Ying Zhangchairman-labor union
- Pui Ling WanFinancial Controller, Company Secretary
- Yi Xin LengNon-Executive Director
- Jian Ping WangNon-Executive Director
- Xiao Ping YuNon-Executive Director
- Xian Biao ZengNon-Executive Director
- Ms. Mun Wah ChengNon-Executive Independent Director
- Mr. Rong Xin ShuNon-Executive Independent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Changmao Biochemical Engineering produces organic acids with four-carbon structures for food and pharmaceutical industries.
- Changmao Biochemical Engineering operates in Mainland China, Europe, Asia Pacific, and America.
- Changmao Biochemical Engineering has 574 full-time employees supporting its production and trade activities.
Weaknesses
- Changmao Biochemical Engineering's products are limited to organic acids and their derivatives.
- Changmao Biochemical Engineering's main market is food additive industries, chemical industries, and pharmaceutical industries.
- Changmao Biochemical Engineering's business is concentrated in Mainland China, Europe, Asia Pacific, and America.
Opportunities
- Changmao Biochemical Engineering can expand its product range beyond organic acids and their derivatives.
- Changmao Biochemical Engineering can enter new markets in Africa and South America.
- Changmao Biochemical Engineering can increase its presence in the growing pharmaceutical industry.
Threats
- Changmao Biochemical Engineering faces competition from other chemical companies in the organic acids market.
- Changmao Biochemical Engineering may encounter regulatory changes in the food additive industry.
- Changmao Biochemical Engineering could be affected by economic downturns in Europe and Asia Pacific.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.